Journal of Endocrinology

References

1. ↵
   1. Abe T,
   2. Kakyo M,
   3. Sakagami H,
   4. Tokui T,
   5. Nishio T,
   6. Tanemoto M,
   7. Nomura H,
   8. Hebert SC,
   9. Matsuno S,
   10. Kondo H
   11. et al.

   1998 Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. Journal of Biological Chemistry 273 22395–22401doi:10.1074/jbc.273.35.22395.
2. ↵
   1. Alam MI,
   2. Beg S,
   3. Samad A,
   4. Baboota S,
   5. Kohli K,
   6. Ali J,
   7. Ahuja A &
   8. Akbar M

   2010 Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences 40 385–403doi:10.1016/j.ejps.2010.05.003.
3. ↵
   1. Allikmets R,
   2. Schriml LM,
   3. Hutchinson A,
   4. Romano-Spica V &
   5. Dean M

   1998 A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Research 58 5337–5339.
4. ↵
   1. Almquist KC,
   2. Loe DW,
   3. Hipfner DR,
   4. Mackie JE,
   5. Cole SP &
   6. Deeley RG

   1995 Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Cancer Research 55 102–110.
5. ↵
   1. Aouida M,
   2. Poulin R &
   3. Ramotar D

   2010 The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5. Journal of Biological Chemistry 285 6275–6284doi:10.1074/jbc.M109.046151.
6. ↵
   1. Augustine LM,
   2. Markelewicz RJJ,
   3. Boekelheide K &
   4. Cherrington NJ

   2005 Xenobiotic and endobiotic transporter mRNA expression in the blood–testis barrier. Drug Metabolism and Disposition 33 182–189doi:10.1124/dmd.104.001024.
7. ↵
   1. Ban N,
   2. Sasaki M,
   3. Sakai H,
   4. Ueda K &
   5. Inagaki N

   2005 Cloning of ABCA17, a novel rodent sperm-specific ABC (ATP-binding cassette) transporter that regulates intracellular lipid metabolism. Biochemical Journal 389 577–585doi:10.1042/BJ20050159.
8. ↵
   1. Bart J,
   2. Hollema H,
   3. Groen HJ,
   4. de Vries EG,
   5. Hendrikse NH,
   6. Sleijfer DT,
   7. Wegman TD,
   8. Vaalburg W &
   9. van der Graaf WT

   2004 The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumours. European Journal of Cancer 40 2064–2070doi:10.1016/j.ejca.2004.05.010.
9. ↵
   1. Bera TK,
   2. Iavarone C,
   3. Kumar V,
   4. Lee S,
   5. Lee B &
   6. Pastan I

   2002 MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. PNAS 99 6997–7002doi:10.1073/pnas.102187299.
10. ↵
    1. Bermingham JRJ &
    2. Pennington J

    2004 Organization and expression of the SLC36 cluster of amino acid transporter genes. Mammalian Genome 15 114–125doi:10.1007/s00335-003-2319-3.
11. ↵
    1. van der Bliek AM,
    2. Kooiman PM,
    3. Schneider C &
    4. Borst P

    1988 Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 71 401–411doi:10.1016/0378-1119(88)90057-1.
12. ↵
    1. Boesch D,
    2. Gaveriaux C,
    3. Jachez B,
    4. Pourtier-Manzanedo A,
    5. Bollinger P &
    6. Loor F

    1991 In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC833. Cancer Research 51 4226–4233.
13. ↵
    1. Brower JV,
    2. Lim CH,
    3. Jorgensen M,
    4. Oh SP &
    5. Terada N

    2009 Adenine nucleotide translocase 4 deficiency leads to early meiotic arrest of murine male germ cells. Reproduction 138 463–470doi:10.1530/REP-09-0201.
14. ↵
    1. Carreau S &
    2. Hess RA

    2010 Oestrogens and spermatogenesis. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 365 1517–1535doi:10.1098/rstb.2009.0235.
15. ↵
    1. Carreau S,
    2. Wolczynski S &
    3. Galeraud-Denis I

    2010 Aromatase, oestrogens and human male reproduction. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 365 1571–1579doi:10.1098/rstb.2009.0113.
16. ↵
    1. Chauvin TR &
    2. Griswold MD

    2004 Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biology of Reproduction 70 744–751doi:10.1095/biolreprod.103.022731.
17. ↵
    1. Chen ZQ,
    2. Annilo T,
    3. Shulenin S &
    4. Dean M

    2004 Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse chromosome 7F3. Mammalian Genome 15 335–343doi:10.1007/s00335-004-2281-8.
18. ↵
    1. Cheng CY &
    2. Mruk DD

    2009 An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective. Critical Reviews in Biochemistry and Molecular Biology 44 245–263doi:10.1080/10409230903061207.
19. ↵
    1. Cheng CY &
    2. Mruk DD

    2010a The biology of spermatogenesis: the past, present and future. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 365 1459–1463doi:10.1098/rstb.2010.0024.
20. ↵
    1. Cheng CY &
    2. Mruk DD

    2010b A local autocrine axis in the testes that regulates spermatogenesis. Nature Reviews. Endocrinology 6 380–395doi:10.1038/nrendo.2010.71.
21. ↵
    1. Cheng CY &
    2. Mruk DD

    2010c New frontiers in non-hormonal male contraception. Contraception 82 476–482doi:10.1016/j.contraception.2010.03.017.
22. ↵
    1. Cheng CY,
    2. Mruk D,
    3. Silvestrini B,
    4. Bonanomi M,
    5. Wong CH,
    6. Siu MK,
    7. Lee NP,
    8. Lui WY &
    9. Mo MY

    2005 AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data. Contraception 72 251–261doi:10.1016/j.contraception.2005.03.008.
23. ↵
    1. Cheng CY,
    2. Wong EW,
    3. Yan HH &
    4. Mruk DD

    2010 Regulation of spermatogenesis in the microenvironment of the seminiferous epithelium: new insights and advances. Molecular and Cellular Endocrinology 315 49–56doi:10.1016/j.mce.2009.08.004.
24. ↵
    1. Choudhuri S &
    2. Klaassen CD

    2006 Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. International Journal of Toxicology 25 231–259doi:10.1080/10915810600746023.
25. ↵
    1. Cole SP,
    2. Bhardwaj G,
    3. Gerlach JH,
    4. Mackie JE,
    5. Grant CE,
    6. Almquist KC,
    7. Stewart AJ,
    8. Kurz EU,
    9. Duncan AM &
    10. Deeley RG

    1992 Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 1650–1654doi:10.1126/science.1360704.
26. ↵
    1. Couture L,
    2. Nash JA &
    3. Turgeon J

    2006 The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacological Reviews 58 244–258doi:10.1124/pr.58.2.7.
27. ↵
    1. Croop JM,
    2. Raymond M,
    3. Haber D,
    4. Devault A,
    5. Arceci RJ,
    6. Gros P &
    7. Housman DE

    1989 The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Molecular and Cellular Biology 9 1346–1350.
28. ↵
    1. Crowley E &
    2. Callaghan R

    2009 Multidrug efflux pumps: drug binding – gates or cavity? FEBS Journal 277 530–539doi:10.1111/j.1742-4658.2009.07484.x.
29. ↵
    1. Dallas S,
    2. Miller DS &
    3. Bendayan R

    2006 Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacological Reviews 58 140–161doi:10.1124/pr.58.2.3.
30. ↵
    1. Dalton TP,
    2. He L,
    3. Wang B,
    4. Miller ML,
    5. Jin L,
    6. Stringer KF,
    7. Chang X,
    8. Baxter CS &
    9. Nebert DW

    2005 Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. PNAS 102 3401–3406doi:10.1073/pnas.0406085102.
31. ↵
    1. Dean M,
    2. Rzhetsky A &
    3. Allikmets R

    2001 The human ATP-binding cassette (ABC) transporter superfamily. Genome Research 11 1156–1166doi:10.1101/gr.GR-1649R.
32. ↵
    1. Delclos KB,
    2. Bucci TJ,
    3. Lomax LG,
    4. Latendresse JR,
    5. Warbritton A,
    6. Weis CC &
    7. Newbold RR

    2001 Effects of dietary genistein exposure during development on male and female CD (Sprague–Dawley) rats. Reproductive Toxicology 15 647–663doi:10.1016/S0890-6238(01)00177-0.
33. ↵
    1. Doyle LA,
    2. Yang W,
    3. Abruzzo LV,
    4. Krogmann T,
    5. Gao Y,
    6. Rishi AK &
    7. Ross DD

    1998 A multidrug resistance transporter from human MCF-7 breast cancer cells. PNAS 95 15665–15670doi:10.1073/pnas.95.26.15665.
34. ↵
    1. Elgazar V,
    2. Razanov V,
    3. Stoltenberg M,
    4. Hershfinkel M,
    5. Huleihel M,
    6. Nitzan YB,
    7. Lunenfeld E,
    8. Sekler I &
    9. Silverman WF

    2005 Zinc-regulating proteins, ZnT-1, and metallothionein I/II are present in different cell populations in the mouse testis. Journal of Histochemistry and Cytochemistry 53 905–912doi:10.1369/jhc.4A6482.2005.
35. ↵
    1. Elliott AM &
    2. Al-Hajj MA

    2009 ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome. Molecular Cancer Research 7 79–87doi:10.1158/1541-7786.MCR-08-0235.
36. ↵
    1. Enokizono J,
    2. Kusuhara H &
    3. Sugiyama Y

    2007 Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Molecular Pharmacology 72 967–975doi:10.1124/mol.107.034751.
37. ↵
    1. Enokizono J,
    2. Kusuhara H,
    3. Ose A,
    4. Schinkel AH &
    5. Sugiyama Y

    2008 Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metabolism and Disposition 36 995–1002doi:10.1124/dmd.107.019257.
38. ↵
    1. Enomoto A,
    2. Wempe MF,
    3. Tsuchida H,
    4. Shin HJ,
    5. Cha SH,
    6. Anzai N,
    7. Goto A,
    8. Sakamoto A,
    9. Niwa T,
    10. Kanai Y
    11. et al.

    2002 Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. Journal of Biological Chemistry 277 36262–36271doi:10.1074/jbc.M203883200.
39. ↵
    1. Evers R,
    2. Zaman GJ,
    3. van Deemter L,
    4. Jansen H,
    5. Calafat J,
    6. Oomen LC,
    7. Oude Elferink RP,
    8. Borst P &
    9. Schinkel AH

    1996 Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. Journal of Clinical Investigation 97 1211–1218doi:10.1172/JCI118535.
40. ↵
    1. Fardel O &
    2. Le Vee M

    2009 Regulation of human drug transporter expression by pro-inflammatory cytokines. Expert Opinion on Drug Metabolism and Toxicology 5 1469–1481doi:10.1517/17425250903304056.
41. ↵
    1. Fahrmayr C,
    2. Fromm MF &
    3. Konig J

    2010 Hepatic OATP and OCT uptake transporters: their role for drug–drug interactions and pharmacogenetic aspects. Drug Metabolism Reviews 42 380–401doi:10.3109/03602530903491683.
42. ↵
    1. Fetsch PA,
    2. Abati A,
    3. Litman T,
    4. Morisaki K,
    5. Honjo Y,
    6. Mittal K &
    7. Bates SE

    2006 Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Letters 235 84–92doi:10.1016/j.canlet.2005.04.024.
43. ↵
    1. Fitzgerald ML,
    2. Mujawar Z &
    3. Tamehiro N

    2010 ABC transporters, atherosclerosis and inflammation. Atherosclerosis 211 361–370doi:10.1016/j.atherosclerosis.2010.01.011.
44. ↵
    1. Flens MJ,
    2. Izquierdo MA,
    3. Scheffer GL,
    4. Fritz JM,
    5. Meijer CJ,
    6. Scheper RJ &
    7. Zaman GJ

    1994 Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Research 54 4557–4563.
45. ↵
    1. Flens MJ,
    2. Zaman GJ,
    3. van der Valk P,
    4. Izquierdo MA,
    5. Schroeijers AB,
    6. Scheffer GL,
    7. van der Groep P,
    8. de Haas M,
    9. Meijer CJ &
    10. Scheper RJ

    1996 Tissue distribution of the multidrug resistance protein. American Journal of Pathology 148 1237–1247.
46. ↵
    1. Ford JM

    1995 Modulators of multidrug resistance. Preclinical studies. Hematology/Oncology Clinics of North America 9 337–361.
47. ↵
    1. Franke RM,
    2. Gardner ER &
    3. Sparreboom A

    2010 Pharmacogenetics of drug transporters. Current Pharmaceutical Design 16 220–230doi:10.2174/138161210790112683.
48. ↵
    1. Fromm MF

    2004 Importance of P-glycoprotein at blood–tissue barriers. Trends in Pharmacological Sciences 25 423–429doi:10.1016/j.tips.2004.06.002.
49. ↵
    1. Ganta S,
    2. Deshpande D,
    3. Korde A &
    4. Amiji M

    2010 A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers. Molecular Membrane Biology 27 260–273doi:10.3109/09687688.2010.497971.
50. ↵
    1. Gaucher G,
    2. Satturwar P,
    3. Jones M-C,
    4. Furtos A &
    5. Leroux J-C

    2010 Polymeric micelles for oral drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 76 147–158doi:10.1016/j.ejpb.2010.06.007.
51. ↵
    1. Green MM

    2010 2010: a century of Drosophila genetics through the prism of the white gene. Genetics 184 3–7doi:10.1534/genetics.109.110015.
52. ↵
    1. Grichtchenko II,
    2. Choi I,
    3. Zhong X,
    4. Bray-Ward P,
    5. Russell JM &
    6. Boron WF

    2001 Cloning, characterization, and chromosomal mapping of a human electroneutral Na(+)-driven Cl–HCO₃ exchanger. Journal of Biological Chemistry 276 8358–8363doi:10.1074/jbc.C000716200.
53. ↵
    1. Griffin KP,
    2. Ward DT,
    3. Liu W,
    4. Stewart G,
    5. Morris ID &
    6. Smith CP

    2005 Differential expression of divalent metal transporter DMT1 (Slc11a2) in the spermatogenic epithelium of the developing and adult rat testis. American Journal of Physiology. Cell Physiology 288 C176–C184doi:10.1152/ajpcell.00061.2004.
54. ↵
    1. Gros P,
    2. Raymond M,
    3. Bell J &
    4. Housman D

    1988 Cloning and characterization of a second member of the mouse mdr gene family. Molecular and Cellular Biology 8 2770–2778.
55. ↵
    1. Cheng CY

    1. Hess RA &
    2. de Franca LR

    2008 Spermatogenesis and cycle of the seminiferous epithelium. In Molecular Mechanisms in Spermatogenesis, pp 1–15. Ed. Cheng CY. Austin, TX: Landes Bioscience/Springer Science+Business Media, LLC.
56. ↵
    1. Hipfner DR,
    2. Gauldie SD,
    3. Deeley RG &
    4. Cole SP

    1994 Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Research 54 5788–5792.
57. ↵
    1. Höftberger R,
    2. Kunze M,
    3. Weinhofer I,
    4. Aboul-Enein F,
    5. Voigtländer T,
    6. Oezen I,
    7. Amann G,
    8. Bernheimer H,
    9. Budka H &
    10. Berger J

    2007 Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiology of Disease 28 165–174doi:10.1016/j.nbd.2007.07.007.
58. ↵
    1. Hu JH,
    2. He XB &
    3. Yan YC

    2000 Identification of γ-aminobutyric acid transporter (GAT1) on the rat sperm. Cell Research 10 51–58doi:10.1038/sj.cr.7290035.
59. ↵
    1. Hu JH,
    2. Yang N,
    3. Ma YH,
    4. Jiang J,
    5. Zhang JF,
    6. Fei J &
    7. Guo LH

    2004 Identification of glutamate transporters and receptors in mouse testis. Acta Pharmacologica Sinica 25 366–371.
60. ↵
    1. Hu GX,
    2. Hu LF,
    3. Yang DZ,
    4. Li JW,
    5. Chen GR,
    6. Chen BB,
    7. Mruk DD,
    8. Bonanomi M,
    9. Silvestrini B,
    10. Cheng CY
    11. et al.

    2009 Adjudin targeting rabbit germ cell adhesion as a male contraceptive: a pharmacokinetics study. Journal of Andrology 30 87–93doi:10.2164/jandrol.108.004994.
61. ↵
    1. Huisman MT,
    2. Smit JW,
    3. Crommentuyn KM,
    4. Zelcer N,
    5. Wiltshire HR,
    6. Beijnen JH &
    7. Schinkel AH

    2002 Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs. AIDS 16 2295–2301doi:10.1097/00002030-200211220-00009.
62. ↵
    1. Ibberson M,
    2. Riederer BM,
    3. Uldry M,
    4. Guhl B,
    5. Roth J &
    6. Thorens B

    2002 Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons. Endocrinology 143 276–284doi:10.1210/en.143.1.276.
63. ↵
    1. Inagaki N,
    2. Gonoi T,
    3. Clement JP,
    4. Wang CZ,
    5. Aguilar-Bryan L,
    6. Bryan J &
    7. Seino S

    1996 A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K⁺ channels. Neuron 16 1011–1017doi:10.1016/S0896-6273(00)80124-5.
64. ↵
    1. Jégou B

    1992 The Sertoli cell. Bailliere's Clinical Endocrinology and Metabolism 6 273–311doi:10.1016/S0950-351X(05)80151-X.
65. ↵
    1. Jeulin C &
    2. Lewin LM

    1996 Role of free l-carnitine and acetyl-l-carnitine in post-gonadal maturation of mammalian spermatozoa. Human Reproduction Update 2 87–102doi:10.1093/humupd/2.2.87.
66. ↵
    1. Jonker JW &
    2. Schinkel AH

    2004 Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1–3). Journal of Pharmacology and Experimental Therapeutics 308 2–9doi:10.1124/jpet.103.053298.
67. ↵
    1. Jonker JW,
    2. Smit JW,
    3. Brinkhuis RF,
    4. Maliepaaed M,
    5. Beijnen JH,
    6. Schellens JH &
    7. Schinkel AH

    2000 Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. Journal of the National Cancer Institute 92 1651–1656doi:10.1093/jnci/92.20.1651.
68. ↵
    1. Jonker JW,
    2. Wagenaar E,
    3. Mol CA,
    4. Buitelaar M,
    5. Koepsell H,
    6. Smit JW &
    7. Schinkel AH

    2001 Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Molecular and Cellular Biology 21 5471–5477doi:10.1128/MCB.21.16.5471-5477.2001.
69. ↵
    1. Jonker JW,
    2. Wagenaar E,
    3. van Eijl S &
    4. Schinkel AH

    2003 Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Molecular and Cellular Biology 23 7902–7908doi:10.1128/MCB.23.21.7902-7908.2003.
70. ↵
    1. Kaisman-Elbaz T,
    2. Sekler I,
    3. Fishman D,
    4. Karol N,
    5. Forberg M,
    6. Kahn N,
    7. Hershfinkel M &
    8. Silverman WF

    2009 Cell death induced by zinc and cadmium is mediated by clusterin in cultured mouse seminiferous tubules. Journal of Cellular Physiology 220 222–229doi:10.1002/jcp.21754.
71. ↵
    1. Kalliokoski A &
    2. Niemi M

    2009 Impact of OATP transporters on pharmacokinetics. British Journal of Pharmacology 158 693–705doi:10.1111/j.1476-5381.2009.00430.x.
72. ↵
    1. Keppler D,
    2. Leier I &
    3. Jedlitschky G

    1997 Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biological Chemistry 378 787–791.
73. ↵
    1. Keppler D,
    2. Cui Y,
    3. König J,
    4. Leier I &
    5. Nies A

    1999 Export pumps for anionic conjugates encoded by MRP genes. Advances in Enzyme Regulation 39 237–246doi:10.1016/S0065-2571(98)00015-6.
74. ↵
    1. Kim ST &
    2. Moley KH

    2007 The expression of GLUT8, GLUT9a, and GLUT9b in the mouse testis and sperm. Reproductive Sciences 14 445–455doi:10.1177/1933719107306228.
75. ↵
    1. Kis O,
    2. Robillard K,
    3. Chan GN &
    4. Bendayan R

    2010 The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters. Trends in Pharmacological Sciences 31 22–35doi:10.1016/j.tips.2009.10.001.
76. ↵
    1. Klaassen CD &
    2. Aleksunes LM

    2010 Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacological Reviews 62 1–96doi:10.1124/pr.109.002014.
77. ↵
    1. Klein T,
    2. Cooper TG &
    3. Yeung CH

    2006 The role of potassium chloride cotransporters in murine and human sperm volume regulation. Biology of Reproduction 75 853–858doi:10.1095/biolreprod.106.054064.
78. ↵
    1. Kobayashi D,
    2. Goto A,
    3. Maeda T,
    4. Nezu J,
    5. Tsuji A &
    6. Tamai I

    2005 OCTN2-mediated transport of carnitine in isolated Sertoli cells. Reproduction 129 729–736doi:10.1530/rep.1.00507.
79. ↵
    1. Kobayashi D,
    2. Tamai I,
    3. Sai Y,
    4. Yoshida K,
    5. Wakayama T,
    6. Kido Y,
    7. Nezu J,
    8. Iseki S &
    9. Tsuji A

    2007 Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa. Reproduction 134 651–658doi:10.1530/REP-06-0173.
80. ↵
    1. Koepsell H,
    2. Lips K &
    3. Volk C

    2007 Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharmaceutical Research 24 1227–1251doi:10.1007/s11095-007-9254-z.
81. ↵
    1. König J,
    2. Rost D,
    3. Cui Y &
    4. Keppler D

    1999 Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29 1156–1163doi:10.1002/hep.510290404.
82. ↵
    1. Kool M,
    2. van der Linden M,
    3. de Haas M,
    4. Scheffer GL,
    5. de Vree JM,
    6. Smith AJ,
    7. Jansen G,
    8. Peters GJ,
    9. Ponne N,
    10. Scheper RJ
    11. et al.

    1999 MRP3, an organic anion transporter able to transport anti-cancer drugs. PNAS 96 6914–6919doi:10.1073/pnas.96.12.6914.
83. ↵
    1. Koshiba S,
    2. An R,
    3. Saito H,
    4. Wakabayashi K,
    5. Tamura A &
    6. Ishikawa T

    2008 Human ABC transporters ABCG2 (BCRP) and ABCG4. Xenobiotica 38 863–888doi:10.1080/00498250801986944.
84. ↵
    de Kretser DM & Kerr JB 1988 The cytology of the testis. In: The Physiology of Reproduction, vol 1, pp 837–932. Eds E Knobil, JB Neill, LL Ewing, GS Greenwald, CL Markert & DW Pfaff. New York: Raven Press..
85. ↵
    1. Krishnamachary N,
    2. Ma L,
    3. Zheng L,
    4. Safa AR &
    5. Center MS

    1994 Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncology Research 6 119–127.
86. ↵
    1. Krishnamurthy PC,
    2. Du G,
    3. Fukuda Y,
    4. Sun D,
    5. Sampath J,
    6. Mercer KE,
    7. Wang J,
    8. Sosa-Pineda B,
    9. Murti KG &
    10. Schuetz JD

    2006 Identification of a mammalian mitochondrial porphyrin transporter. Nature 443 586–589doi:10.1038/nature05092.
87. ↵
    1. Kyselova V,
    2. Peknicova J,
    3. Boubelik M &
    4. Buckiova D

    2004 Body and organ weight, sperm acrosomal status and reproduction after genistein and diethylstilbestrol treatment of CD1 mice in a multigenerational study. Theriogenology 61 1307–1325doi:10.1016/j.theriogenology.2003.07.017.
88. ↵
    1. Lassalle B,
    2. Bastos H,
    3. Louis JP,
    4. Riou L,
    5. Testart J,
    6. Dutrillaux B,
    7. Fouchet P &
    8. Allemand I

    2004 ‘Side Population’ cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells. Development 131 479–487doi:10.1242/dev.00918.
89. ↵
    1. Lautier D,
    2. Canitrot Y,
    3. Deeley RG &
    4. Cole SP

    1996 Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochemical Pharmacology 52 967–977doi:10.1016/0006-2952(96)00450-9.
90. ↵
    1. Leslie EM,
    2. Deeley RG &
    3. Cole SP

    2005 Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicology and Applied Pharmacology 204 216–237doi:10.1016/j.taap.2004.10.012.
91. ↵
    1. Leuthold S,
    2. Hagenbuch B,
    3. Mohebbi N,
    4. Wagner CA,
    5. Meier PJ &
    6. Stieger B

    2009 Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. American Journal of Physiology. Cell Physiology 296 C570–C582doi:10.1152/ajpcell.00436.2008.
92. ↵
    1. Lhuillier P,
    2. Rode B,
    3. Escalier D,
    4. Lorès P,
    5. Dirami T,
    6. Bienvenu T,
    7. Gacon G,
    8. Dulioust E &
    9. Touré A

    2009 Absence of annulus in human asthenozoospermia: case report. Human Reproduction 24 1296–1303doi:10.1093/humrep/dep020.
93. ↵
    1. Li L,
    2. Meier PJ &
    3. Ballatori N

    2000 Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Molecular Pharmacology 58 335–340.
94. ↵
    1. Li MW,
    2. Mruk DD,
    3. Lee WM &
    4. Cheng CY

    2009 Cytokines and junction restructuring events during spermatogenesis in the testis: an emerging concept of regulation. Cytokine & Growth Factor Reviews 20 329–338doi:10.1016/j.cytogfr.2009.07.007.
95. ↵
    1. Li Y,
    2. Yuan H,
    3. Yang K,
    4. Xu W,
    5. Tang W &
    6. Li X

    2010 The structure and function of P-glycoprotein. Current Medicinal Chemistry 17 786–800doi:10.2174/092986710790514507.
96. ↵
    1. Loe DW,
    2. Almquist KC,
    3. Deeley RG &
    4. Cole SP

    1996 Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. Journal of Biological Chemistry 271 9675–9682doi:10.1074/jbc.271.44.27782.
97. ↵
    1. Lohi H,
    2. Kujala M,
    3. Makela S,
    4. Lehtonen E,
    5. Kestila M,
    6. Saarialho-Kere U,
    7. Markovich D &
    8. Kere J

    2002 Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. Journal of Biological Chemistry 277 14246–14254doi:10.1074/jbc.M111802200.
98. ↵
    1. Lorico A,
    2. Bertola A,
    3. Baum C,
    4. Fodstad O &
    5. Rappa G

    2002 Role of the multidrug resistance protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochemical and Biophysical Research Communications 291 617–622doi:10.1006/bbrc.2002.6489.
99. ↵
    1. Maeda T,
    2. Goto A,
    3. Kobayashi D &
    4. Tamai I

    2007 Transport of organic cations across the blood–testis barrier. Molecular Pharmaceutics 4 600–607doi:10.1021/mp070023l.
100. ↵
     1. Maliepaard M,
     2. Scheffer GL,
     3. Faneyte IF,
     4. van Gastelen MA,
     5. Pijnenborg AC,
     6. Schinkel AH,
     7. van De Vijver MJ,
     8. Scheper RJ &
     9. Schellens JH

     2001 Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Research 61 3458–3464.
101. ↵
     1. Marzolini C,
     2. Paus E,
     3. Buclin T &
     4. Kim RB

     2004 Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clinical Pharmacology and Therapeutics 75 13–33doi:10.1016/j.clpt.2003.09.012.
102. ↵
     1. McMahon RJ &
     2. Cousins RJ

     1998 Mammalian zinc transporters. Journal of Nutrition 128 667–670.
103. ↵
     1. Meinhardt A &
     2. Hedger MP

     2010 Immunological, paracrine and endocrine aspects of testicular immune privilege. Molecular and Cellular Endocrinologydoi:10.1016/j.mce.2010.03.022.
104. ↵
     1. Melaine N,
     2. Lienard MO,
     3. Dorval I,
     4. Le Goascogne C,
     5. Lejeune H &
     6. Jegou B

     2002 Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, guinea pig, and human. Biology of Reproduction 67 1699–1707doi:10.1095/biolreprod.102.003558.
105. ↵
     1. Melaine N,
     2. Satie AP,
     3. Lassurguère J,
     4. Desmots S,
     5. Jégou B &
     6. Samson M

     2006 Molecular cloning of several rat ABC transporters including a new ABC transporter, Abcb8, and their expression in rat testis. International Journal of Andrology 29 392–399doi:10.1111/j.1365-2605.2005.00616.x.
106. ↵
     1. Mikkaichi T,
     2. Suzuki T,
     3. Onogawa T,
     4. Tanemoto M,
     5. Mizutamari H,
     6. Okada M,
     7. Chaki T,
     8. Masuda S,
     9. Tokui T,
     10. Eto N
     11. et al.

     2004 Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. PNAS 101 3569–3574doi:10.1073/pnas.0304987101.
107. ↵
     1. Miller DS

     2010 Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier. Trends in Pharmacological Sciences 31 246–254doi:10.1016/j.tips.2010.03.003.
108. ↵
     1. Miller DS,
     2. Bauer B &
     3. Hartz AM

     2008 Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacological Reviews 60 196–209doi:10.1124/pr.107.07109.
109. ↵
     1. Morales CR,
     2. Marat AL,
     3. Ni X,
     4. Yu Y,
     5. Oko R,
     6. Smith BT &
     7. Argraves WS

     2008 ATP-binding, cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. Biochemical and Biophysical Research Communications 376 472–477doi:10.1016/j.bbrc.2008.09.009.
110. ↵
     1. Morrow CM,
     2. Mruk DD,
     3. Cheng CY &
     4. Hess RA

     2010 Claudin and occludin expression and function in the seminiferous epithelium. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 365 1679–1696doi:10.1098/rstb.2010.0025.
111. ↵
     1. Mruk DD &
     2. Cheng CY

     2010 Tight junctions in the testis: new perspectives. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 365 1621–1635doi:10.1098/rstb.2010.0010.
112. ↵
     1. Mruk DD,
     2. Silvestrini B &
     3. Cheng CY

     2008 Anchoring junctions as drug targets: role in contraceptive development. Pharmacological Reviews 60 146–180doi:10.1124/pr.107.07105.
113. ↵
     1. Muller MB,
     2. Keck ME,
     3. Binder EB,
     4. Kresse AE,
     5. Hagemeyer TP,
     6. Landgraf R,
     7. Holsboer F &
     8. Uhr M

     2003 ABCB1 (MDR1)-type P-glycoproteins at the blood–brain barrier modulate the activity of the hypothalamic–pituitary–adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 1991–1999doi:10.1038/sj.npp.1300257.
114. ↵
     1. Nenicu A,
     2. Lüers GH,
     3. Kovacs W,
     4. David M,
     5. Zimmer A,
     6. Bergmann M &
     7. Baumgart-Vogt E

     2007 Peroxisomes in human and mouse testis: differential expression of peroxisomal proteins in germ cells and distinct somatic cell types of the testis. Biology of Reproduction 77 1060–1072doi:10.1095/biolreprod.107.061242.
115. ↵
     1. Ni Z,
     2. Bikadi Z,
     3. Rosenberg MF &
     4. Mao Q

     2010 Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Current Drug Metabolism 11 603–617doi:10.2174/138920010792927325.
116. ↵
     1. Nishimura M &
     2. Naito S

     2005 Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metabolism and Pharmacokinetics 20 452–477doi:10.2133/dmpk.20.452.
117. ↵
     1. Nishino J,
     2. Suzuki H,
     3. Sugiyama D,
     4. Kitazawa T,
     5. Ito K,
     6. Hanano M &
     7. Sugiyama Y

     1999 Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. Journal of Pharmacology and Experimental Therapeutics 290 289–294.
118. ↵
     1. Ohtsuki S,
     2. Takizawa T,
     3. Takanaga H,
     4. Hori S,
     5. Hosoya K &
     6. Terasaki T

     2004 Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. Journal of Neurochemistry 90 743–749doi:10.1111/j.1471-4159.2004.02549.x.
119. ↵
     1. Ono N,
     2. Van der Heijden I,
     3. Scheffer GL,
     4. van de Wetering K,
     5. van Deemter E,
     6. De Haas M,
     7. Boerke A,
     8. Gadella BM,
     9. De Rooij DG,
     10. Neefjes JJ
     11. et al.

     2007 Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. Biochemical Journal 406 31–40doi:10.1042/BJ20070292.
120. ↵
     1. Petry F,
     2. Ritz V,
     3. Meineke C,
     4. Middel P,
     5. Kietzmann T,
     6. Schmitz-Salue C &
     7. Hirsch-Ernst KI

     2006 Subcellular localization of rat Abca5, a rat ATP-binding-cassette transporter expressed in Leydig cells, and characterization of its splice variant apparently encoding a half-transporter. Biochemical Journal 393 79–87doi:10.1042/BJ20050808.
121. ↵
     1. Pizzagalli F,
     2. Hagenbuch B,
     3. Stieger B,
     4. Klenk U,
     5. Folkers G &
     6. Meier PJ

     2002 Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Molecular Endocrinology 16 2283–2296doi:10.1210/me.2001-0309.
122. ↵
     1. Pritchard JB &
     2. Miller DS

     1993 Mechanisms mediating renal secretion of organic anions and cations. Physiological Reviews 73 765–796.
123. ↵
     1. Rappa G,
     2. Finch RA,
     3. Sartorelli AC &
     4. Lorico A

     1999 New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. Biochemical Pharmacology 58 557–562doi:10.1016/S0006-2952(99)00074-X.
124. ↵
     1. Renes J,
     2. de Vries EG,
     3. Nienhuis EF,
     4. Jansen PL &
     5. Muller M

     1999 ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. British Journal of Pharmacology 126 681–688doi:10.1038/sj.bjp.0702360.
125. ↵
     1. Rochat B

     2009 Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents. Current Cancer Drug Targets 9 652–674doi:10.2174/156800909789056999.
126. ↵
     1. Roelofsen H,
     2. Vos TA,
     3. Schippers IJ,
     4. Kuipers F,
     5. Koning H,
     6. Moshage H,
     7. Jansen PL &
     8. Müller M

     1997 Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112 511–521doi:10.1053/gast.1997.v112.pm9024305.
127. ↵
     1. Ross DD &
     2. Nakanishi T

     2010 Impact of breast cancer resistance protein on cancer treatment outcomes. Methods in Molecular Biology 596 251–290doi:10.1007/978-1-60761-416-6_12.
128. ↵
     1. Ruetz S &
     2. Gros P

     1994 Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77 1071–1081doi:10.1016/0092-8674(94)90446-4.
129. ↵
     1. Schaub TP,
     2. Kartenbeck J,
     3. König J,
     4. Vogel O,
     5. Witzgall R,
     6. Kriz W &
     7. Keppler D

     1997 Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. Journal of the American Society of Nephrology 8 1213–1221.
130. ↵
     1. Schinkel AH

     1999 P-Glycoprotein, a gatekeeper in the blood–brain barrier. Advanced Drug Delivery Reviews 36 179–194doi:10.1016/S0169-409X(98)00085-4.
131. ↵
     1. Schinkel AH &
     2. Jonker JW

     2003 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews 55 3–29doi:10.1016/S0169-409X(02)00169-2.
132. ↵
     1. Schinkel AH,
     2. Wagenaar E,
     3. Mok CA &
     4. van Deemter L

     1996 P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation 97 2517–2524doi:10.1172/JCI118699.
133. ↵
     1. Schmitt BM &
     2. Koepsell H

     2005 Alkali cation binding and permeation in the rat organic cation transporter rOCT2. Journal of Biological Chemistry 280 24481–24490doi:10.1074/jbc.M414550200.
134. ↵
     1. Sekine T,
     2. Cha SH &
     3. Endou H

     2000 The multispecific organic anion transporter (OAT) family. Pflügers Archiv: European Journal of Physiology 440 337–350doi:10.1007/s004240000297.
135. ↵
     1. Selva DM,
     2. Hirsch-Reinshagen V,
     3. Burgess B,
     4. Zhou S,
     5. Chan J,
     6. McIsaac S,
     7. Hayden MR,
     8. Hammond GL,
     9. Vogl AW &
     10. Wellington CL

     2004 The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility. Journal of Lipid Research 45 1040–1050doi:10.1194/jlr.M400007-JLR200.
136. ↵
     1. Cheng CY

     1. Setchell BP

     2008 Blood–testis barrier, junctional and transport proteins and spermatogenesis. In Molecular Mechanisms in Spermatogenesis, pp 212–233. Ed. Cheng CY. Austin, TX: Landes Bioscience/Springer Science+Business Media, LLC.
137. ↵
     1. Cheng CY

     1. Shaha C

     2008 Estrogens and spermatogenesis. In Molecular Mechanisms in Spermatogenesis, pp 42–64. Ed. Cheng CY. Austin, TX: Landes Bioscience/Springer Science+Business Media, LLC.
138. ↵
     1. Knobil E &
     2. Neill JD

     1. Sharpe RM

     1994 Regulation of spermatogenesis. In The Physiology of Reproduction, pp 1363–1434. Eds Knobil E & Neill JD. New York, NY: Raven Press.
139. ↵
     1. Shen S &
     2. Zhang W

     2010 ABC transporters and drug efflux at the blood–brain barrier. Reviews in the Neurosciences 21 29–53.
140. ↵
     1. Shukla S,
     2. Ohnuma S &
     3. Ambudkar SW

     2010 Improving cancer chemotherapy with modulators of ABP drug transporters. Current Drug Targets(In Press).
141. ↵
     1. Smit JJ,
     2. Schinkel AH,
     3. Oude Elferink RP,
     4. Groen AK,
     5. Wagenaar E,
     6. van Deemter L,
     7. Mol CA,
     8. Ottenhoff R,
     9. van der Lugt NM,
     10. van Roon MA
     11. et al.

     1993 Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 451–462doi:10.1016/0092-8674(93)90380-9.
142. ↵
     1. Stewart PA,
     2. Beliveau R &
     3. Rogers KA

     1996 Cellular localization of P-glycoprotein in brain versus gonadal capillaries. Journal of Histochemistry and Cytochemistry 44 679–685doi:10.1177/44.7.8675989.
143. ↵
     1. St-Pierre MV,
     2. Serrano MA,
     3. Macias RI,
     4. Dubs U,
     5. Hoechli M,
     6. Lauper U,
     7. Meier PJ &
     8. Marin JJ

     2000 Expression of members of the multidrug resistance protein family in human term placenta. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 R1495–R1503.
144. ↵
     1. Su L,
     2. Cheng CY &
     3. Mruk DD

     2009 Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood–testis barrier. International Journal of Biochemistry and Cell Biology 41 2578–2587doi:10.1016/j.biocel.2009.08.015.
145. ↵
     1. Suzuki T,
     2. Onogawa T,
     3. Asano N,
     4. Mizutamari H,
     5. Mikkaichi T,
     6. Tanemoto M,
     7. Abe M,
     8. Satoh F,
     9. Unno M,
     10. Nunoki K
     11. et al.

     2003 Identification and characterization of novel rat and human gonad-specific organic anion transporters. Molecular Endocrinology 17 1203–1215doi:10.1210/me.2002-0304.
146. ↵
     1. Tamai I,
     2. Ohashi R,
     3. Nezu JI,
     4. Sai Y,
     5. Kobayashi D,
     6. Oku A,
     7. Shimane M &
     8. Tsuji A

     2000 Molecular and functional characterization of organic cation/carnitine transporter family in mice. Journal of Biological Chemistry 275 40064–40072doi:10.1074/jbc.M005340200.
147. ↵
     1. Tamai I,
     2. China K,
     3. Sai Y,
     4. Kobayashi D,
     5. Nezu J,
     6. Kawahara E &
     7. Tsuji A

     2001 Na(+)-coupled transport of l-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochimica et Biophysica Acta 1512 273–284doi:10.1016/S0005-2736(01)00328-5.
148. ↵
     1. Tanaka Y,
     2. Slitt AL,
     3. Leazer TM,
     4. Maher JM &
     5. Klaassen CD

     2005 Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochemical and Biophysical Research Communications 326 181–187doi:10.1016/j.bbrc.2004.11.012.
149. ↵
     1. Thiebaut F,
     2. Tsuruo T,
     3. Hamada H,
     4. Gottesman MM,
     5. Pastan I &
     6. Willingham MC

     1987 Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. PNAS 84 7735–7738doi:10.1073/pnas.84.21.7735.
150. ↵
     1. Tomi M &
     2. Hosoya KI

     2010 The role of blood–ocular barrier transporters in retinal drug disposition: an overview. Expert Opinion on Drug Metabolism and Toxicology 6 1111–1124doi:10.1517/17425255.2010.486401.
151. ↵
     1. Toure A,
     2. Morin L,
     3. Pineau C,
     4. Becq F,
     5. Dorseuil O &
     6. Gacon G

     2001 Tat1, a novel sulfate transporter specifically expressed in human male germ cells and potentially linked to rhogtpase signaling. Journal of Biological Chemistry 276 20309–20315doi:10.1074/jbc.M011740200.
152. ↵
     1. Touré A,
     2. Lhuillier P,
     3. Gossen JA,
     4. Kuil CW,
     5. Lhôte D,
     6. Jégou B,
     7. Escalier D &
     8. Gacon G

     2007 The testis anion transporter 1 (Slc26a8) is required for sperm terminal differentiation and male fertility in the mouse. Human Molecular Genetics 16 1783–1793doi:10.1093/hmg/ddm117.
153. ↵
     1. Traba J,
     2. Satrústegui J &
     3. del Arco A

     2009 Characterization of SCaMC-3-like/slc25a41, a novel calcium-independent mitochondrial ATP-Mg/Pi carrier. Biochemical Journal 418 125–133doi:10.1042/BJ20081262.
154. ↵
     1. Trezise AE &
     2. Buchwald M

     1991 In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353 434–437doi:10.1038/353434a0.
155. ↵
     1. Trezise AE,
     2. Romano PR,
     3. Gill DR,
     4. Hyde SC,
     5. Sepúlveda FV,
     6. Buchwald M &
     7. Higgins CF

     1992 The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO Journal 11 4291–4303.
156. ↵
     1. Tribull TE,
     2. Bruner RH &
     3. Bain LJ

     2003 The multidrug resistance-associated protein 1 transports methoxychlor and protects the seminiferous epithelium from injury. Toxicology Letters 142 61–70doi:10.1016/S0378-4274(02)00485-X.
157. ↵
     1. Walters HC,
     2. Craddock AL,
     3. Fusegawa H,
     4. Willingham MC &
     5. Dawson PA

     2000 Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. American Journal of Physiology. Gastrointestinal and Liver Physiology 279 G1188–G1200.
158. ↵
     1. Westlake CJ,
     2. Qian YM,
     3. Gao M,
     4. Vasa M,
     5. Cole SP &
     6. Deeley RG

     2003 Identification of the structural and functional boundaries of the multidrug resistance protein 1 cytoplasmic loop 3. Biochemistry 42 14099–14113doi:10.1021/bi035333y.
159. ↵
     1. Wijnholds J,
     2. Scheffer GL,
     3. van der Valk M,
     4. van der Valk P,
     5. Beijnen JH,
     6. Scheper RJ &
     7. Borst P

     1998 Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. Journal of Experimental Medicine 188 797–808doi:10.1084/jem.188.5.797.
160. ↵
     1. Wisniewski AB,
     2. Klein SL,
     3. Lakshmanan Y &
     4. Gearhart JP

     2003 Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. Journal of Urology 169 1582–1586doi:10.1097/01.ju.0000046780.23389.e0.
161. ↵
     1. Wong CH &
     2. Cheng CY

     2005 The blood–testis barrier: its biology, regulation and physiological role in spermatogenesis. Current Topics in Developmental Biology 71 263–296doi:10.1016/S0070-2153(05)71008-5.
162. ↵
     1. Wong EW &
     2. Cheng CY

     2009 Polarity proteins and cell-cell interactions in the testis. International Review of Cell and Molecular Biology 278 309–353doi:10.1016/S1937-6448(09)-78007-4.
163. ↵
     1. Wright SR,
     2. Boag AH,
     3. Valdimarsson G,
     4. Hipfner DR,
     5. Campling BG,
     6. Cole SP &
     7. Deeley RG

     1998 Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung. Clinical Cancer Research 4 2279–2289.
164. ↵
     1. Yakushiji K,
     2. Kai S,
     3. Yamauchi M,
     4. Kuwajima M,
     5. Osada Y &
     6. Toshimori K

     2006 Expression and distribution of OCTN2 in mouse epididymis and its association with obstructive azoospermia in juvenile visceral steatosis mice. International Journal of Urology 13 420–426doi:10.1111/j.1442-2042.2006.01303.x.
165. ↵
     1. Yu M,
     2. Zhang W,
     3. Qin L,
     4. Tian L &
     5. Zhou C

     2010 Enhancement of P-glycoprotein expression by hepatocyte transplantation in carbon tetrachloride-induced rat liver. Anatomical Record 293 1167–1174doi:10.1002/ar.21160.
166. ↵
     1. Zhang J,
     2. Gui Y,
     3. Yuan T,
     4. Bian C &
     5. Guo L

     2009 Expression of GAT1 in male reproductive system and its effects on reproduction in mice. Systems Biology in Reproductive Medicine 55 175–180doi:10.3109/19396360903030500.
167. ↵
     1. Zwart R,
     2. Verhaagh S,
     3. Buitelaar M,
     4. Popp-Snijders C &
     5. Barlow DP

     2001 Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Molecular and Cellular Biology 21 4188–4196doi:10.1128/MCB.21.13.4188-4196.2001.